Answers are grounded in this paper and cite their sources.
Demonstrates the regulation of TH2 to TH17 cell conversion in mice, suggesting new targets for autoimmune therapy.
Multiple sclerosis (MS) is a neurodegenerative autoimmune disease primarily mediated by T helper 17 (T H 17) cells. We previously showed that Itch/WWP2 double knockout (DKO) T cells produce high levels of type 2 cytokines, driving spontaneous autoinflammation. Here, we report that DKO T H 2-high carrying autoantigen-specific TCR (2D2) develop atypical spontaneous experimental autoimmune encephalomyelitis (EAE), with CD4 + T cells simultaneously producing IL-4 and GM-CSF, directly causing neuroinflammation. Unexpectedly, IL-4 deletion in DKO T H 2-high 2D2 mice exacerbates T H 17-driven classical EAE, indicating a T H 2 to T H 17 conversion. Furthermore, we show that the JAK3/STAT5 signaling pathway is critical for maintaining T H 2 lineage stability by modulating Blimp1 and c-Maf thereby suppressing T H 17 differentiation. Importantly, we find that this phenomenon can also be observed in dupilumab-treated patients with atopic dermatitis who develop psoriasis. Thus, our findings uncover the molecular antagonism and plasticity in the T H 2 and T H 17 cell programs and identify potential therapeutic targets for modulating T H 2 and T H 17 cell responses in autoimmune diseases.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: